Using MR-Measured Cerebral Blood Flow to Assess Stroke Risk in Pediatric Sickle Cell Patients

Amanda K. Wake¹, John C. Gore¹

The purpose of this presentation is to highlight the potential for using phase contrast MR (PCMR) to quantify cerebral blood flow to determine stroke risk in pediatric sickle cell disease patients. Because of the ramifications of cerebrovascular accidents in this patient population, it is vital to accurately assess cerebral blood flow, and phase contrast MR (PCMR) is singularly well suited for this application.